This provision proves particularly valuable in NAION cases where patients may not immediately connect their vision loss to medication use, especially given that Ozempic labels did not warn about this risk
Always speak with your doctor before making any adjustments
By Indication (Type-2 Diabetes, Obesity/Weight Management, and Other Emerging Indications): The type 2 diabetes segment is projected to reach USD 169.62 billion by 2033, supported by rising global diabetes prevalence, established clinical efficacy of GLP-1 therapies, and continued physician preference for managing blood glucose and metabolic risks
Inflamm Bowel Dis 2009;15:134-40
Reduces Appetite: This medication acts on parts of the brain that control hunger
The test analyzes your GLP1R, GIPR, FTO, and MC4R variants across 14 metabolic pathways to reveal your individual inflammatory and weight-loss response patterns